Last week, I had tea with a big brother in the circle. He casually showed me a screenshot—using Injective's OpenAI Pre-IPO stock contract, a small position earned a ride-sharing car. I was stunned on the spot. Such Pre-IPO shares of top unicorns, how could ordinary people have access to them before?

Yet, Injective, this top-tier L1 trading platform, has turned the impossible into the possible. It not only supports perpetual contracts on stocks, commodities like gold and silver, but is also the first to bring Pre-IPO assets like OpenAI onto the blockchain, directly breaking through traditional financial privilege barriers.

I've always believed that RWA (Real-World Assets) is the key for Web3 to connect with the real world, and Injective just happens to hit this trend. It has over 700,000 global community users, collaborates with major institutions like Coinbase and BlackRock, and has an exclusive RWA module for technical support—making it compliant and secure. The RWA market has already grown into a multi-hundred-billion-dollar track, and Injective continues to expand into stocks, funds, stablecoins, and other asset types. This ambition to tokenize all financial markets on-chain is truly exciting.

2026 will definitely be the year Injective explodes! With clearer regulations and its own ecosystem advantages, it might even unlock more innovative on-chain asset opportunities we haven't imagined. Personally, whether you're an investor looking to enter the RWA track or a user wanting to experience new financial tools, keep a close eye on Injective. Don't miss this potential stock.

@InjectiveLabsCN @injective #RWA